LLY - Eli Lilly in charts: Mounjaro Zepbound Verzenio and Jardiance drive revenue growth in Q1; Trulicity declines 26%
2024-04-30 07:03:41 ET
More on Eli Lilly
- Eli Lilly And The Alzheimer's Dilemma (Rating Upgrade)
- Wall Street Lunch: Lilly In Limelight
- Eli Lilly: Three Threats To Its Huge Rally
- Eli Lilly Non-GAAP EPS of $2.58 beats by $0.09, revenue of $8.77B misses by $160M
- Eli Lilly Q1 Earnings Preview: Weight loss therapies to drive quarterly growth